-
Subject Areas on Research
-
A Qualitative Exploration of Barriers to Treatment Among HPV-Positive Women in a Cervical Cancer Screening Study in Western Kenya.
-
A Qualitative Exploration of Women's Experiences with a Community Health Volunteer-Led Cervical Cancer Educational Module in Migori County, Kenya.
-
A Review and Update on Papillary Immature Metaplasia of the Uterine Cervix: A Distinct Subset of Low-Grade Squamous Intraepithelial Lesion, Proposing a Possible Cell of Origin.
-
A high association of oncogenic human papillomaviruses with carcinomas of the female urethra: polymerase chain reaction-based analysis of multiple histological types.
-
A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer.
-
A public health approach to cervical cancer screening in Africa through community-based self-administered HPV testing and mobile treatment provision.
-
Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation.
-
Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation.
-
Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
-
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
-
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
-
Anal human papillomavirus and HIV: A cross-sectional study among men who have sex with men in Moscow, Russia, 2012-2013.
-
Anal-rectal cytology: a review.
-
Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients.
-
Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries.
-
Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
-
Assessing university students' sexual risk behaviors as predictors of human papillomavirus (HPV) vaccine uptake behavior.
-
Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.
-
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.
-
CDKN2 in HPV-positive and HPV-negative cervical-carcinoma cell lines.
-
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
-
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
-
Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
-
Characterization of gut-derived intraepithelial lymphocyte (IEL) residing in human papillomavirus (HPV)-infected intraepithelial neoplastic lesions.
-
Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
-
Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions.
-
Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening.
-
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).
-
Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
-
Cost-effectiveness of a potential vaccine for human papillomavirus.
-
Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries.
-
Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?
-
Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization.
-
Developing a framework to describe stigma related to cervical cancer and HPV in western Kenya.
-
Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites.
-
Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
-
Different strokes for different folks: new paradigms for staging oropharynx cancer.
-
Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
-
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.
-
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age.
-
Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
-
Evaluation of Women's Empowerment in a Community-Based Human Papillomavirus Self-Sampling Social Entrepreneurship Program (Hope Project) in Peru: A Mixed-Method Study.
-
Examining Associations between Knowledge and Vaccine Uptake Using the Human Papillomavirus Knowledge Questionnaire (HPV-KQ).
-
Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
-
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
-
Factors Associated With Human Papillomavirus Vaccine Series Completion Among Adolescents.
-
Feasibility of clinical evaluation of individuals with increased risk for HPV-associated oropharynx cancer.
-
Female perspectives on male involvement in a human-papillomavirus-based cervical cancer-screening program in western Kenya.
-
Gene Editing: A New Tool for Viral Disease.
-
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing.
-
Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.
-
HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA.
-
HPV-16-related DNA sequences in Kaposi's sarcoma.
-
Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas.
-
How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya.
-
Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.
-
Human Papillomavirus-Associated Sexual Risks Among High School Students in the U.S.: Does Sexual Orientation Play a Role?
-
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
-
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.
-
Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication.
-
Human papillomavirus in early laryngeal carcinoma.
-
Human papillomavirus infection. Frequency and association with cervical neoplasia in a young population.
-
Human papillomavirus prevalence in a population of women living in Port-au-Prince and Leogane, Haiti.
-
Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.
-
Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction.
-
Human papillomavirus types important in progression of inverted papilloma.
-
Immunotherapy for gynaecological malignancies.
-
Increased Rate of ASCUS Diagnosis With Concomitant Request for High-Risk Human Papillomavirus Reflex Testing May Be Due to Cognitive Bias.
-
Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.
-
Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
-
Knowledge about human papillomavirus among adolescents.
-
Long and short gracilis myocutaneous flaps for vulvovaginal reconstruction after radical pelvic surgery: comparison of flap-specific complications.
-
Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers.
-
Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.
-
Methods for analyzing bovine papilloma virus-based calmodulin expression vectors.
-
Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
-
Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra.
-
Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction.
-
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.
-
Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
-
Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
-
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.
-
Presence of human papillomavirus predicts recurrence of inverted papilloma.
-
Prevalence of human papillomavirus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic lesions by differential polymerase chain reaction.
-
Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial.
-
Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.
-
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
-
Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection.
-
RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells.
-
Racial and Ethnic Differences in Acceptability of Urine and Cervico-Vaginal Sample Self-Collection for HPV-Based Cervical Cancer Screening.
-
Re: Detection of human papillomavirus in squamous neoplasm of the penis.
-
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
-
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
-
Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells.
-
Reprogramming of cellular metabolic pathways by human oncogenic viruses.
-
Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.
-
Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
-
Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers.
-
Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.
-
Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
-
Self-efficacy and HPV Vaccine Attitudes Mediate the Relationship Between Social Norms and Intentions to Receive the HPV Vaccine Among College Students.
-
Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
-
Sociodemographic Factors Associated With Knowledge and Risk Perception of Human Papillomavirus and Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Among a Predominantly Black Population.
-
Stage 1 small cell cancer of the vagina.
-
Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya.
-
Subsequent malignant neoplasms in the Childhood Cancer Survivor Study: Occurrence of cancer types in which human papillomavirus is an established etiologic risk factor.
-
Survival of human papillomavirus-associated cancers: Filling in the gaps.
-
Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
-
Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.
-
The association of oncogenic human papillomaviruses with urologic malignancy. The controversies and clinical implications.
-
The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
-
The role of human papilloma virus infection in the etiology of oropharyngeal carcinoma.
-
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens.
-
Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
-
Vaginal Self-Sampling for Human Papillomavirus Infection as a Primary Cervical Cancer Screening Tool in a Haitian Population.
-
Virus-induced experimental brain tumors and putative associations of viruses with human brain tumors: a review.
-
Widespread flat warts associated with human papillomavirus type 5: a cutaneous manifestation of human immunodeficiency virus infection.
-
p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.
-
Keywords of People
-
Berchuck, Andrew,
James M. Ingram Distinguished Professor of Gynecologic Oncology,
Obstetrics and Gynecology, Gynecologic Oncology
-
Cohen, Seth Morris,
Professor of Head and Neck Surgery & Communication Sciences,
Head and Neck Surgery & Communication Sciences
-
Esclamado, Ramon Mitra,
Professor Emeritus of Head and Neck Surgery & Communication Sciences,
Head and Neck Surgery & Communication Sciences